Author/Authors :
Bayar, Nermin Antalya Education and Research Hospital - Department of Cardiology, Turkey , Arslan, Şakir Antalya Education and Research Hospital - Department of Cardiology, Turkey , Köklü, Erkan Antalya Education and Research Hospital - Department of Cardiology, Turkey , Kuş, Görkem Antalya Education and Research Hospital - Department of Cardiology, Turkey
Abstract :
In current guidelines, target INR value is 3.0 for patients who underwent mechanical mitral valve replacement as is known. However, AHA/ ACC Valvular Heart Disease guideline that published in March 2014 recommends to be kept high levels of target INR (3.5-4.5) for patients who successfully treated with thrombolytic therapy due to mitral PVT. In our case, INR value was 1.58 and PVT which associated with inadequate anticoagulation has been considered. Due to PVT had not occured in target INR values; our patient was discharged after successful thrombolytic therapy, when our patient’s INR value was reached to 3.5.
